BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//NextConsensus//Registered forecast deadlines//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:FF-012 deadline
X-WR-CALDESC:Event deadlines of registered forecasts. Dates\, names\, and l
 inks only.
REFRESH-INTERVAL;VALUE=DURATION:P1D
X-PUBLISHED-TTL:PT24H
BEGIN:VEVENT
UID:ff-012@nextconsensus.com
DTSTAMP:20261006T000000Z
DTSTART;VALUE=DATE:20261101
DTEND;VALUE=DATE:20261102
SUMMARY:FF-012 deadline: Mitapivat · sickle cell supplement approval
DESCRIPTION:Registered forecast FF-012 (FDA)\, Mitapivat · sickle cell sup
 plement approval. It asks whether this happens by 2026-11-01. The record: 
 https://nextconsensus.com/forecast/ff-012/
URL:https://nextconsensus.com/forecast/ff-012/
CATEGORIES:Registered forecast,FDA
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR